Zobrazeno 1 - 4
of 4
pro vyhledávání: '"A B Sugraliyev"'
Autor:
A. B. Sugraliyev, P. Cirillo
Publikováno v:
Атеротромбоз, Vol 12, Iss 1, Pp 114-126 (2022)
The coronavirus disease (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus (SARS-CoV-2) stimulated the development of highly effective vaccines that were produced with unprecedented speed with the use of new technologies. All
Externí odkaz:
https://doaj.org/article/dbff746d927549a1ab197f5ace8356c8
Autor:
A. B. Sugraliyev, Sh. S. Aktayeva, Sh. B. Zhangelova, S. A. Shiller, Zh. M. Kussymzhanova, S. K. Tuganbekova, Zh. S. Sheriyazdan, B. L. Danyarova, V. E. Tsai
Publikováno v:
Атеротромбоз, Vol 0, Iss 1, Pp 26-40 (2021)
Introduction. Venous thromboembolism (VTE) is a major public health issue that is frequently underestimated. The primary objective of this multicenter study was to identify patients at risk for VTE, and to define the rate of patients receiving approp
Externí odkaz:
https://doaj.org/article/aa82b2452df64fe5881df914acbcdb96
Autor:
N P Mitkovskaya, A O Konradi, Komarov Al, E I Tarlovskaya, Ye V Shlyakhto, V A Snezhitskiy, S V Malchikova, A I Chesnikova, L V Kolotsey, M M Petrova, A B Sugraliyev, V V Skibitsky, A G Arutyunov, N. A. Koziolova, Ya A Orlova, Tereshchenko Sn, Kropacheva Es, G P Arutyunov, I. V. Fomin, Yu N Belenkov, Panchenko Ep, I. S. Yavelov, Ardashev Av, I I Shaposhnik, N Yu Grigorieva, G A Dzhunusbekova, S G Kanorskii, A P Rebrov, Hamayak Sisakian, E G Zhelyakov, O. M. Drapkina
Publikováno v:
Kardiologiia. 60:4-14
This article discusses relevant aspects in the treatment of patients with COVID-19. Up-to-date information about principles for administration of statins, antithrombotics, and antiarrhythmics is presented. The authors addressed in detail specific fea
Autor:
A B Sugraliyev
Publikováno v:
Kardiologiia. 61(4)
The novel coronavirus infection, COVID-19, is a highly contagious viral disease associated with acute, severe respiratory syndrome, which is based on the development of pronounced thrombo-inflammatory syndrome. As the number of patients with COVID-19